Pharmacology, clinical pharmacology and potential therapeutic uses of the specific bradycardiac agent alinidine.
Harron
D W
DW
Shanks
R G
RG
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D003000:Clonidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology*; D004341:Drug Evaluation; D006339:Heart Rate / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D009203:Myocardial Infarction / Q000188:drug therapy; D009449:Neurocirculatory Asthenia / Q000188:drug therapy; D009458:Neuroleptanalgesia; D013610:Tachycardia / Q000188:drug therapy / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; C022192:alinidine; D003000:Clonidine